| abstract |
The present invention provides the use of a substituted or unsubstituted linear, branched or cyclic oligosaccharide comprising from 2 to 10 monosaccharide units, for the preparation of a medicament for treating prion disease. The present invention also provides a pharmaceutical composition for treating prion disease, the composition comprising a pharmaceutically effective amount of a substituted or unsubstituted linear, branched or cyclic oligosaccharide comprising from 2 to 10 monosaccharide units, with the exception of unsubstituted β-cyclodextrin, and a pharmaceutically acceptable excipient. |